(Q28378827)

English

Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9)

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9) (English)

0 references

1 reference

V M Reddy

1

0 references

G Nadadhur

series ordinal

2

0 references

D Daneluzzi

series ordinal

3

0 references

V Dimova

series ordinal

4

0 references

P R Gangadharam

series ordinal

5

0 references

language of work or name

English

0 references

publication date

October 1995

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

39

0 references

issue

10

0 references

page(s)

2320-4

0 references

cites work

In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strains

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

20 March 2017

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

20 March 2017

Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

20 March 2017

Rifampicin, a general review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

29 September 2017

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

2 June 2018

LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162936

retrieved

2 June 2018

Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8619589

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.39.10.2320

0 references

PMC publication ID

162936

0 references

PubMed publication ID

8619589

0 references

(Q28378827)

Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)